Results for tag: "Pimecrolimus"

Pimecrolimus is a topical immunomodulator used in the treatment of atopic dermatitis, a chronic inflammatory skin condition. It is a calcineurin inhibitor, meaning it works by blocking the release of certain chemicals that cause inflammation. Pimecrolimus is available in cream and ointment forms, and is applied directly to the affected area of skin. It is generally used as a second-line treatment after topical corticosteroids, and is not recommended for use in children under two years of age. Pimecrolimus is a relatively new drug, and is not yet widely available. It is currently marketed by several pharmaceutical companies, including Novartis, Galderma, and Leo Pharma. It is also available in generic forms from several generic drug manufacturers. The market for pimecrolimus is growing, as more people are being diagnosed with atopic dermatitis and seeking treatment. It is becoming increasingly popular as an alternative to topical corticosteroids, which can have significant side effects. Companies in the pimecrolimus market include Novartis, Galderma, Leo Pharma, and several generic drug manufacturers. Show Less Read more